Revvity (RVTY) Net Cash Flow (2009 - 2026)
Revvity's (RVTY) quarterly Net Cash Flow came in at $165.3 million in Q3 2026, up 188.37% on a YoY basis from $57.3 million in Q3 2025, and up 500.38% quarter-over-quarter from -$41.3 million in Q2 2026.
Analysis
Revvity (RVTY) Net Cash Flow (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Net Cash Flow for 18 consecutive years, with $165.3 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Net Cash Flow rose 188.37% year-over-year to $165.3 million; the trailing twelve-month figure through Jul 2026 stood at $14.2 million (up 104.83% YoY), and the FY2025 full-year result was -$342.2 million, down 209.36% from the prior year.
- Net Cash Flow improved to $165.3 million in Q3 2026 per RVTY's latest filing, from -$41.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $1.8 billion in Q2 2023 and bottomed at -$942.8 million in Q3 2023.
- Historically, Net Cash Flow has averaged $39.2 million across 5 years, with a median of -$38.1 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow surged 1636.89% in 2023, then tumbled 258.01% in 2025.
- Over 5 years, Net Cash Flow stood at $105.0 million in 2022, then plunged by 147.35% to -$49.7 million in 2023, then grew by 29.86% to -$34.9 million in 2024, then surged by 57.53% to -$14.8 million in 2025, then soared by 1216.59% to $165.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $165.3 million, -$41.3 million, and -$14.8 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 718.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -1.34 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -42.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -50.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 165.28 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 55.15 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 4.40 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 24.48 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 12.26 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 46.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 165.28 Mn |
| Apr 5, 2026 | -41.28 Mn |
| Dec 28, 2025 | -14.80 Mn |
| Sep 28, 2025 | -95.02 Mn |
| Jun 29, 2025 | -187.03 Mn |
| Mar 30, 2025 | -45.32 Mn |
| Dec 29, 2024 | -34.85 Mn |
| Sep 29, 2024 | -26.54 Mn |
| Jun 30, 2024 | 277.32 Mn |
| Mar 31, 2024 | 96.95 Mn |
| Dec 31, 2023 | -49.69 Mn |
| Oct 1, 2023 | -184.67 Mn |
| Jul 2, 2023 | -942.84 Mn |
| Apr 2, 2023 | 1.82 Bn |
| Jan 1, 2023 | -217.88 Mn |
| Apr 3, 2022 | 104.96 Mn |
| Oct 3, 2021 | -231.72 Mn |
| Jul 4, 2021 | -259.89 Mn |
| Apr 4, 2021 | 594.64 Mn |
| Jan 3, 2021 | 119.13 Mn |